VABYSMO (faricimab-svoa) is a prescription medication used to treat adults with certain eye conditions. It is administered by injection into the eye and is designed to block two causes of vision loss: vascular endothelial growth factor (VEGF) and angiopoietin-2. VABYSMO is FDA-approved for treating neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO).